Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04915898
Other study ID # 18.074.06
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date April 30, 2020

Study information

Verified date February 2024
Source Orlando Health, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of a universal, standardized oral care protocol on prevention of non-ventilated hospital-acquired pneumonia (NV-HAP) in the acute care setting. In the course of the year-long study, the research team will provide educational and materials support for oral hygiene on two interventional units (one medical; one surgical) and two control units (one matched medical; one surgical). At the end of the study, the research team will evaluate existing hospital data to determine the number of NV-HAPs in the interventional and control groups.


Description:

Prior to the study, the research team will have a lead-in period where education will be provided to the interventional groups and demonstration of desired oral care practices for patients (September 1-30, 2018) Design Previous research on the effectiveness of oral care for NV-HAP prevention has primarily relied on pre/post intervention study designs. In order to enhance compliance and avoid contamination of both the treatment and intervention groups, the research proposed the use of cluster randomization. ICD-10 codes and a standardized CDC definition of non-ventilator hospital-acquired pneumonia will be used to determine the baseline incidence on NV-HAP for the 12 months prior to study implementation. The incidence will be expressed as both an overall incidence based on total patient days, as well as a rate per 1000 patient days. The research team will follow the consolidated standards of reporting trials (CONSORT) research methods and reporting for pragmatic trials (2010). The research team will implement the HAPPI protocol using Stetler's model of implementation science. Overall the implementation process will be guided by Influencer Model ™ . Methods There are no experimental procedures or medications use proposed in this study. The study consists of implementing a standardized oral care protocol (Attachment A) which are components of basic nursing care. Previous research has found that opportunities for oral care were often missed as part of daily care. The research team proposed to set specific standards and protocols for delivery of oral care on the intervention unit and to monitor the amount of oral care provided on both the control and intervention units. The evidence-based oral care protocol consists of: - oral care assessment by a RN to determine type and frequency oral care - brushing the teeth with a soft-bristled toothbrush and plaque removing toothpaste - rinsing with a non-alcohol based mouth wash - application of lip and mouth moisturizer - use of 24-hour suction toothbrush kits for high aspiration-risk patients who meet criteria, per oral care protocol The study coordinator will provide educational information and support on the study units for use of the oral care kit and implementation of oral care after meals and before bedtime on the interventional units. As part of validation of oral care, the coordinator will make rounds on patients on the study units and validate and audit oral care activities with the patient/family and encourage their participation in oral care and with documentation checks. On the control units, the coordinator will also make rounds and evaluate oral care frequency in a non-conspicuous manner and through documentation.


Recruitment information / eligibility

Status Completed
Enrollment 8709
Est. completion date April 30, 2020
Est. primary completion date November 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: • in-patient adults (18 and older) in control (one medical/one surgical) and interventional (one medical/one surgical) study units in whom oral care is not contraindicated Exclusion Criteria: - patients who are on mechanical ventilation, intubated orally, or with tracheostomy - patients who have contraindications for oral care.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Oral Hygiene - teeth brushing
Oral hygiene using a special kit with recommended materials and instructions: Use of an ADA approved toothbrush, toothpaste with dentifrice, antiseptic mouthwash and non-drying lip moisturizer encouraged after meals and at bedtime

Locations

Country Name City State
United States Orlando Health Orlando Florida

Sponsors (2)

Lead Sponsor Collaborator
Orlando Health, Inc. Medline Industries

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Compliance to oral care practices The number of oral care practices per patient per day One year - October 1, 2018-September 30, 2019
Primary Reduced non-ventilator hospital acquired pneumonia - NV-HAP Percent reduction of hospital acquired pneumonia One year - October 1, 2018-September 30, 2019
Secondary Incidence of NV- HAP Incidence of NV-HAP per 1000 patient days One year - october 1, 2018-september 30, 2019
See also
  Status Clinical Trial Phase
Completed NCT02070757 - Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008) Phase 3
Recruiting NCT05589727 - Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
Recruiting NCT05354778 - HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study N/A
Completed NCT01285869 - Impact of a Multidimensional Intervention in Elderly Patients With Pneumonia N/A
Enrolling by invitation NCT04055922 - Comparison of Solid Organ Transplant
Completed NCT00610324 - Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients Phase 4
Withdrawn NCT02134106 - Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria Phase 2/Phase 3
Completed NCT04438187 - Trial of Antimicrobial Restraint in Presumed Pneumonia N/A